Association of Pentraxin-3, Galectin-3 and Matrix Metalloproteinase-9/Timp-1 with Cardiovascular Risk in Renal Disease Patients

Inflammation, apoptosis and extracellular remodeling play significant roles in cardiovascular disease (CVD) underlying the major causes of mortality in renal patients. In 19 pre-dialysis patients, 21 dialysis patients and 20 control subjects, the concentrations of pentraxin-3, galectin-3, MMP-9 and...

Full description

Bibliographic Details
Published in:	Acta Clinica Croatica
Main Authors:	Milica Miljković, Aleksandra Stefanović, Nataša Bogavac-Stanojević, Sanja Simić-Ogrizović, Jerka Dumić, Darko Černe, Zorana Jelić-Ivanović, Jelena Kotur-Stevuljević
Format:	Article
Language:	English
Published:	Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2017-01-01
Subjects:	Kidney diseases Pentraxin-3 Galectin-3 Matrix-metalloproteinase-9 Tissue inhibitor of matrix metalloproteinase-1 Cardiovascular diseases
Online Access:	https://hrcak.srce.hr/file/288100

Similar Items

Urinary Metalloproteinases-9 and -2 and Their Inhibitors TIMP-1 and TIMP-2 are Markers of Early and Long-Term Graft Function After Renal Transplantation
by: Ewa Kwiatkowska, et al.
Published: (2016-05-01)

Parameters of the mmp / timp system in assessing the clinical course of pulmonary tuberculoma
by: D. S. Esmedlyaeva, et al.
Published: (2024-04-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity
by: Sanja Dimic-Janjic, et al.
Published: (2023-03-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

Expression of MMP-2, MMP-9 and TIMP-2 in pituitary tumors and their relationship with cavernous sinus invasion
by: Ane Caroline Thé B Freire, et al.
Published: (2025-01-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in children with ventricular septal defect
by: Nina Maric, et al.
Published: (2024-10-01)

Serum matrix metalloproteinase-2,9 activity, galectin-3 and systemic inflammation in patients with postinfarction heart failure with preserved ejection fraction.
by: O. Kuryata, et al.
Published: (2018-04-01)

Exploring the Causal Relationship Between the Plasma Levels of MMP1 (Matrix Metalloproteinase‐1), MMP3, MMP7, MMP10, and MMP12 and Intervertebral Disc Degeneration: Mendelian Randomization
by: Lin Sun, et al.
Published: (2025-03-01)

Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis
by: Yangxue Li, et al.
Published: (2016-01-01)

Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats
by: Jingchao Lu, et al.
Published: (2016-06-01)

The presence of promatrix metalloproteinase-3 and its relation with different categories of coal workers' pneumoconiosis
by: Remzi Altin, et al.
Published: (2004-01-01)

Short-Term Exposure to Wood Smoke Increases the Expression of Pro-Inflammatory Cytokines, Gelatinases, and TIMPs in Guinea Pigs
by: Carlos Ramos, et al.
Published: (2021-09-01)

Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis
by: Małgorzata Kobusiak-Prokopowicz, et al.
Published: (2021-11-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) as a Prognostic Biomarker in Acute Kidney Injury: A Narrative Review
by: Charlotte Delrue, et al.
Published: (2024-06-01)

GALECTIN-3 AND MATRIX METALLOPROTEINASE-1 IN THE PATOGENESIS OF MYOCARDIAL DYSSYNCHRONY IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES
by: T.A. Rudenko
Published: (2016-04-01)

Expression of MMP1, MMP3, and TIMP1 in intervertebral discs under simulated overload and microgravity conditions
by: Xuanyu Chen, et al.
Published: (2025-01-01)

Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice
by: Jing Deng, et al.
Published: (2024-06-01)

Serum and synovial matrix metalloproteinases 1 and 3 in patients with early rheumatoid arthritis: potentially prospective biomarkers of ultrasonographic joint damage and disease activity
by: Maryam A. Abdelrahman, et al.
Published: (2019-01-01)

Maternal Plasma Levels of MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 as Predictive Biomarkers of Preeclampsia
by: Thuy Thanh Nguyen, et al.
Published: (2025-09-01)

Assessment of Matrix Metalloproteinases a Prognostic Indicator in Advanced Fibrotic Lung Disease: A Systematic Review
by: Mehvish Aqil, et al.
Published: (2025-04-01)

Galectin-9 Promotes Human Trophoblast Cell Invasion through Matrix Metalloproteinase-2 and p38 Signaling Pathway
by: Feng-Run Sun, et al.
Published: (2018-01-01)

Proteolysis/antiproteolysis system in apparently healthy men and women of different ages
by: Vladimir N. Yushchuk, et al.
Published: (2024-09-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis
by: Jane B. Maoga, et al.
Published: (2022-03-01)

Structure and computation-guided yeast surface display for the evolution of TIMP-based matrix metalloproteinase inhibitors
by: Alireza Shoari, et al.
Published: (2023-11-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Curcumin – A Potent Inhibitor of Galectin-3 Expression
by: Jerka Dumić, et al.
Published: (2002-01-01)

Structural insights into the biological functions of the long pentraxin PTX3
by: Anna Margherita Massimino, et al.
Published: (2023-10-01)

Total Flavonoids of Scutellaria barbata Inhibit Invasion of Hepatocarcinoma via MMP/TIMP in Vitro
by: Xi-Jing Wang, et al.
Published: (2013-01-01)

Treponema pallidum protein Tp0136 promoting MMPs/TIMPs imbalance via PI3K, MAPK and NF-κB signalling pathways in HDVSMCs
by: Chun-Xiang Cai, et al.
Published: (2022-12-01)

The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)

Chlorogenic acid attenuates cardiac hypertrophy and fibrosis by downregulating galectin 3
by: Seong Hoon Kim, et al.
Published: (2025-07-01)

Eotaxin-induced expression of membrane type 1 matrix metalloproteinase mRNA in human eosinophils
by: Izumi Kurosaki, et al.
Published: (2000-01-01)

Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity
by: Mark Feldman, et al.
Published: (2025-10-01)

Production of factors involved into fibrosis regulation by various types of human macrophages
by: A. A. Maksimova, et al.
Published: (2020-08-01)

Gelatinases A and B activities in the serum of patients with various coronary artery disease stages
by: Radenković Sandra, et al.
Published: (2010-01-01)